Suppr超能文献

白细胞介素-12的施用揭示了基因抗性I-Eα转基因非肥胖糖尿病小鼠中的致糖尿病T细胞:对自身免疫性糖尿病的抗性与Eα衍生肽与I-A(g7)分子的结合有关。

IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.

作者信息

Trembleau S, Gregori S, Penna G, Gorny I, Adorini L

机构信息

Roche Milan Ricerche, Via Olgettina 58, I-20132 Milan, Italy.

出版信息

J Immunol. 2001 Oct 1;167(7):4104-14. doi: 10.4049/jimmunol.167.7.4104.

Abstract

Nonobese diabetic (NOD) and NOD-DRalpha transgenic (tg) mice, expressing Aalpha(d):Abeta(g7) and Aalpha(d):Abeta(g7) plus DRalpha:Ebeta(g7) class II molecules, respectively, both develop insulin-dependent diabetes mellitus (IDDM), whereas NOD-Ealpha tg mice expressing Aalpha(d):Abeta(g7) plus Ealpha:Ebeta(g7) are protected. We show that IL-12 administration induces rapid IDDM onset in NOD-DRalpha but fails to provoke insulitis and diabetes in NOD-Ealpha tg mice. Nevertheless, T cells from IL-12-treated NOD-Ealpha tg mice secrete IFN-gamma and transfer IDDM to NOD-SCID and NOD-Ealpha-SCID recipients, demonstrating the presence of peripheral diabetogenic Th1 cells in the protected mice. Surprisingly, regulatory cells were undetectable. Moreover, Ealpha:Ebeta(g7) could substitute for DRalpha:Ebeta(g7) in Ag presentation, arguing against mechanisms of protection involving capture of diabetogenic I-A(g7)-restricted epitopes by Ealpha:Ebeta(g7)molecules. Interestingly, the expression of naturally processed epitopes derived from DRalpha- and Ealpha-chains bound to I-A(g7) is different in the two strains of tg mice, and the difference is enhanced by IL-12 administration. I-A(g7) molecules from both NOD-DRalpha and NOD-Ealpha tg mice present the conserved DRalpha/Ealpha 52-68 sequence, at high and low levels, respectively. In addition, only IDDM-resistant NOD-Ealpha tg mice possess APCs bearing Ealpha65-77/I-A(g7) complexes, which tolerize the specific T cells. This is associated with the selective inhibition of the response to insulinoma-associated protein 2 (IA-2), an autoantigen in IDDM. Our results support protective mechanisms based on I-A(g7) blockade by peptides unique to the Ealpha-chain, such as Ealpha65-77 and/or tolerance of diabetogenic T cells cross-reactive with Ealpha-peptide/I-A(g7) complexes.

摘要

非肥胖糖尿病(NOD)小鼠和NOD-DRα转基因(tg)小鼠分别表达Aα(d):Aβ(g7)和Aα(d):Aβ(g7)加DRα:Eβ(g7)II类分子,两者都会发展为胰岛素依赖型糖尿病(IDDM),而表达Aα(d):Aβ(g7)加Eα:Eβ(g7)的NOD-Eα tg小鼠受到保护。我们发现,给予白细胞介素-12(IL-12)会使NOD-DRα小鼠迅速发病,但不会在NOD-Eα tg小鼠中引发胰岛炎和糖尿病。然而,来自经IL-12处理的NOD-Eα tg小鼠的T细胞会分泌γ干扰素,并将IDDM转移给NOD-SCID和NOD-Eα-SCID受体,这表明在受保护的小鼠中存在外周致糖尿病的Th1细胞。令人惊讶的是,未检测到调节性细胞。此外,Eα:Eβ(g7)在抗原呈递中可以替代DRα:Eβ(g7),这与涉及Eα:Eβ(g7)分子捕获致糖尿病的I-A(g7)限制性表位的保护机制相悖。有趣的是,在这两种tg小鼠品系中,与I-A(g7)结合的源自DRα链和Eα链的天然加工表位的表达不同,并且这种差异在给予IL-12后会增强。来自NOD-DRα和NOD-Eα tg小鼠的I-A(g7)分子分别以高水平和低水平呈递保守的DRα/Eα 52-68序列。此外,只有抗IDDM的NOD-Eα tg小鼠拥有携带Eα65-77/I-A(g7)复合物的抗原呈递细胞(APC),这些复合物可使特定T细胞产生耐受性。这与对胰岛素瘤相关蛋白2(IA-2)(IDDM中的一种自身抗原)反应的选择性抑制有关。我们的结果支持基于Eα链特有的肽(如Eα65-77)对I-A(g7)的阻断和/或与Eα肽/I-A(g7)复合物交叉反应的致糖尿病T细胞的耐受性的保护机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验